The FDA has given Elekta 510(k) clearance to market its Clarity 4D monitoring technology. The software is designed to allow continuous and real-time viewing of the prostate in patients receiving radiation treatment for prostate cancer.
4D prostate monitoring tool from Elekta wins FDA nod
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management